Patents by Inventor Myoung-don OH

Myoung-don OH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STEREOTYPIC NEUTRALIZING VH CLONOTYPES AGAINST SARS-COV-2 RBD IN COVID-19 PATIENTS AND THE HEALTHY POPULATION
    Publication number: 20210395346
    Abstract: Described are stereotypic-naïve SARS-CoV-2 neutralizing antibodies that inhibit that SARS-CoV-2 virus replication. The antibodies comprise variable heavy chain (VH) clonotypes, encoded by either immunoglobulin heavy variable (IGHV)3-53 or IGHV3-66 and immunoglobulin heavy joining (IGHJ)6, and were identified in IgM, IgG3, IgG1, IgA1, IgG2, and IgA2 subtypes, with minimal somatic mutations, and could be paired with diverse light chains, resulting in binding to the SARS-CoV-2 receptor-binding domain (RBD). One of these clonotypes potently inhibited viral replication.
    Type: Application
    Filed: June 21, 2021
    Publication date: December 23, 2021
    Inventors: Junho CHUNG, Sang iL Kim, Sujeong Kim, Jinsung Noh, Younggeun Choi, Duck Kyun Yoo, Yonghee Lee, Hyunho Lee, Wan Beom Park, Myoung-don oh, Sunghoon Kwon
  • ANTIBODY THAT BINDS TO ENVELOPE GLYCOPROTEIN OF SEVER FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS AND USE FOR SAME
    Publication number: 20210171611
    Abstract: The present invention relates to an antibody which specifically binds to the envelope glycoprotein of severe fever with thrombocytopenia syndrome virus (SFTSV), the pathogen of severe fever with thrombocytopenia syndrome (SFTS), and is used in order to effectively detect or diagnosis SFTSV and treat SFTS.
    Type: Application
    Filed: February 9, 2021
    Publication date: June 10, 2021
    Inventors: Junho CHUNG, Ki-Hyun KIM, Hyori KIM, Myoung-don OH, Wan Beom PARK, Seungtaek KIM, Jinhee KIM, Ji-Young MIN, Meehyun KO
  • Antibody that binds to envelope glycoprotein of severe fever with thrombocytopenia syndrome virus and use for same
    Patent number: 10947299
    Abstract: The present invention relates to an antibody which specifically binds to the envelope glycoprotein of severe fever with thrombocytopenia syndrome virus (SFTSV), the pathogen of severe fever with thrombocytopenia syndrome (SFTS), and is used in order to effectively detect or diagnosis SFTSV and treat SFTS.
    Type: Grant
    Filed: March 23, 2017
    Date of Patent: March 16, 2021
    Assignees: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, INSTITUT PASTEUR KOREA
    Inventors: Junho Chung, Ki-Hyun Kim, Hyori Kim, Myoung-don Oh, Wan Beom Park, Seungtaek Kim, Jinhee Kim, Ji-Young Min, Meehyun Ko
  • ANTIBODY THAT BINDS TO ENVELOPE GLYCOPROTEIN OF SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS AND USE FOR SAME
    Publication number: 20190112360
    Abstract: The present invention relates to an antibody which specifically binds to the envelope glycoprotein of severe fever with thrombocytopenia syndrome virus (SFTSV), the pathogen of severe fever with thrombocytopenia syndrome (SFTS), and is used in order to effectively detect or diagnosis SFTSV and treat SFTS.
    Type: Application
    Filed: March 23, 2017
    Publication date: April 18, 2019
    Inventors: Junho CHUNG, Ki-Hyun KIM, Hyori KIM, Myoung-don OH, Wan Beom PARK, Seungtaek KIM, Jinhee KIM